English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Biospace

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Biotechs move away from troubled Novo Nordisk plant amid FDA scrutiny

+ Pharmaceuticals
Patient Daily | Dec 5, 2025

Eisai remains optimistic about Alzheimer's drug despite industry setbacks

+ Pharmaceuticals
Patient Daily | Dec 4, 2025

FDA says report on alleged child deaths tied to COVID-19 vaccines coming by month’s end

+ Pharmaceuticals
Patient Daily | Dec 4, 2025

Biopharma job postings rise for second month as application rates also climb

+ Pharmaceuticals
Patient Daily | Dec 3, 2025

Capricor reports positive phase III results for DMD cardiomyopathy therapy after initial FDA rejection

+ Pharmaceuticals
Patient Daily | Dec 3, 2025

FDA proposes reducing primate use in antibody therapy testing

+ Pharmaceuticals
Patient Daily | Dec 3, 2025

New UK/EU regulations and AI adoption shape priorities for contract research organizations

+ Pharmaceuticals
Patient Daily | Dec 2, 2025

Experts question FDA official's claims linking child deaths to COVID-19 vaccines

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 51
  • 52
  • 53
  • 54


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily